Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Mar;8(3):226-34.
doi: 10.1038/nrd2804.

Glycosylation as a strategy to improve antibody-based therapeutics

Roy Jefferis  1
Affiliations
Review

Glycosylation as a strategy to improve antibody-based therapeutics

Roy Jefferis. Nat Rev Drug Discov. 2009 Mar.

Abstract

To date, more than 20 recombinant immunoglobulin G (IgG) antibody therapeutics are licensed for the treatment of various diseases. The mechanism of action of recombinant monoclonal antibodies (rMAbs) has been extensively investigated and several distinct pathways have been defined; selective activation of specific pathways may optimize clinical outcomes for different diseases, such as cancer and chronic inflammation. Human IgG is a glycoprotein with oligosaccharides attached at a single site. These are essential to the mode of action of rMAbs, and the antibody efficacy can vary depending on the particular oligosaccharide that is attached. Methods are now becoming available that allow the production of rMAbs bearing pre-selected oligosaccharides - glycoforms - to provide maximum efficacy for a given disease indication. This Review summarizes current knowledge of these methods and avenues for their exploitation in the clinic.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Immunol Methods. 2007 Sep 30;326(1-2):116-26 - PubMed
    1. Nature. 1975 Aug 7;256(5517):495-7 - PubMed
    1. Science. 2006 Aug 4;313(5787):670-3 - PubMed
    1. Adv Immunol. 2004;82:155-215 - PubMed
    1. Nat Rev Immunol. 2008 Aug;8(8):607-18 - PubMed

LinkOut - more resources